Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 8/20 | 0.60 |
| ▸ | HEXA | P06865 | 3/20 | 0.58 |
| ▸ | HEXB | P07686 | 3/20 | 0.58 |
| ▸ | AGXT | P21549 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29913152 | 0.89 | DHFR (0.64) | DHFRHEXAHEXB | |
| SCHEMBL12368253 | 0.74 | HEXA (1.00) | DHFRHEXAHEXB | |
| SCHEMBL4611806 | 0.73 | DHFR (0.71) | DHFR | |
| SCHEMBL29913145 | 0.73 | DHFR (1.00) | DHFRHEXAHEXB | |
| SCHEMBL11881285 | 0.73 | DHFR (1.00) | DHFRHEXAHEXB | |
| SCHEMBL3498787 | 0.72 | HEXA (1.00) | DHFRHEXAHEXB | |
| SCHEMBL8925824 | 0.71 | — | — | |
| SCHEMBL14320394 | 0.71 | AGXT (0.56) | DHFRAGXT | |
| SCHEMBL4507051 | 0.71 | AGXT (0.65) | AGXT | |
| SCHEMBL29913249 | 0.70 | CYP1A2 (0.73) | DHFRHEXAHEXB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289686-A1 | COMPOSITIONS OF NRF2 INHIBITING AGENTS AND METHODS OF USE THEREOF | WASHINGTON UNIVERSITY | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289686-A1 | COMPOSITIONS OF NRF2 INHIBITING AGENTS AND METHODS OF USE THEREOF | KEAP1, GSTK1, NFE2L2 | DHFR 1701/4885HEXA 3816/4885HEXB 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.